| Net income | 4.44B |
| Gain (loss) on equity method investees | 39M |
| Compensation payable in common stock and options | 794M |
| Depreciation and amortization | 1.36B |
| Gain on business dispositions | |
| Gain on sale of securities available for sale | -127M |
| Loss on repurchase of long-term debt | |
| Insurance reimbursement | |
| Loss on assets held for sale | |
| Impairment charges and other-than-temporary impairment charges | 102M |
| Cash deposited with clearing organizations or segregated under federal and other regulations or requirements | |
| Financial instruments owned, net of financial instruments sold, not yet purchased | -20.51B |
| Securities borrowed | 16.14B |
| Securities loaned | -2.84B |
| Receivables, loans and other assets | -2.8B |
| Payables and other liabilities | 3.8B |
| Federal funds sold and securities purchased under agreements to resell | -2.92B |
| Securities sold under agreements to repurchase | 10.24B |
| Net cash provided by (used for) operating activities | |
| Net proceeds from (payments for): | |
| Premises, equipment and software costs | -941M |
| Business acquisitions, net of cash acquired | |
| Business dispositions, net of cash disposed | |
| Japanese securities joint venture with MUFG | |
| Purchases of securities available for sale | |
| Sales and redemptions of securities available for sale | |
| Net cash provided by (used for) investing activities | |
| Net proceeds from (payments for): | |
| Commercial paper and other short-term borrowings | -1.23B |
| Dividends related to noncontrolling interests | |
| Derivatives financing activities | |
| Other secured financings | -278M |
| Deposits | -4.19B |
| Excess tax benefits associated with stock-based awards | 51M |
| Public offerings and other issuances of common stock | |
| Issuance of long-term borrowings | 27.53B |
| Long-term borrowings | -22.9B |
| Repurchases of common stock for employee tax withholding | |
| Cash dividends | -1.31B |
| Net cash provided by (used for) financing activities | |
| Effect of exchange rate changes on cash and cash equivalents | 1.05B |
| Effect of cash and cash equivalents related to variable interest entities | |
| Net increase in cash and cash equivalents | -11.53B |
| Cash and cash equivalents, at beginning of period | 54.08B |
| Cash and cash equivalents, at end of period | 42.55B |
| Cash and due from banks | 26.9B |
| Interest bearing deposits with banks | 15.65B |
| Cash and cash equivalents, at end of period | |